Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II
- Author
- NEUMANN, H. P. H1 ; ENG, C; MULLIGAN, L. M; GLAVAC, D; ZÄUNER, I1 ; PONDER, B. A. J; CROSSEY, P. A; MAHER, E. R; BRAUCH, H
[1] Albert-Ludwigs-univ. Freiburg, dep. nephrology hypertension, Germany - Source
JAMA, the journal of the American Medical Association. 1995, Vol 274, Num 14, pp 1149-1151 ; ref : 21 ref
- ISSN
- 0098-7484
- Scientific domain
- General medicine general surgery
- Publisher
- American Medical Association, Chicago, IL
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Etude familiale Evaluation performance Exploration Homme Lignée germinale Mutation Polyadénomatose endocrinienne II Endocrinopathie Maladie héréditaire Tumeur maligne
- Keyword (en)
- Family study Performance evaluation Exploration Human Germ line Mutation Multiple endocrine neoplasia type II Endocrinopathy Genetic disease Malignant tumor
- Keyword (es)
- Estudio familiar Evaluación prestación Exploración Hombre Línea germinal Mutación Neoplasia endocrina múltiple tipo II Endocrinopatía Enfermedad hereditaria Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21G General aspects. Associated endocrine diseases. Endocrine paraneoplasic syndromes
- Discipline
- Endocrinopathies
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2895779
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1001/jama.1995.03530140061033 
https://dx.doi.org/10.1001/jama.1995.03530140061033
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1001\/jama.1995.03530140061033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:3:\"274\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1149\";s:8:\"\u0000*\u0000epage\";s:4:\"1151\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"NEUMANN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"H. P. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:6:\"ENG, C\";i:1;s:14:\"MULLIGAN, L. M\";i:2;s:9:\"GLAVAC, D\";i:3;s:10:\"Z\u00c4UNER, I\";i:4;s:15:\"PONDER, B. A. J\";i:5;s:13:\"CROSSEY, P. A\";i:6;s:11:\"MAHER, E. R\";i:7;s:9:\"BRAUCH, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1001\/jama.1995.03530140061033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:3:\"274\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1149\";s:8:\"\u0000*\u0000epage\";s:4:\"1151\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"NEUMANN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"H. P. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:6:\"ENG, C\";i:1;s:14:\"MULLIGAN, L. M\";i:2;s:9:\"GLAVAC, D\";i:3;s:10:\"Z\u00c4UNER, I\";i:4;s:15:\"PONDER, B. A. J\";i:5;s:13:\"CROSSEY, P. A\";i:6;s:11:\"MAHER, E. R\";i:7;s:9:\"BRAUCH, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1001\/jama.1995.03530140061033\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1001\/jama.1995.03530140061033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:3:\"274\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1149\";s:8:\"\u0000*\u0000epage\";s:4:\"1151\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"NEUMANN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"H. P. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:6:\"ENG, C\";i:1;s:14:\"MULLIGAN, L. M\";i:2;s:9:\"GLAVAC, D\";i:3;s:10:\"Z\u00c4UNER, I\";i:4;s:15:\"PONDER, B. A. J\";i:5;s:13:\"CROSSEY, P. A\";i:6;s:11:\"MAHER, E. R\";i:7;s:9:\"BRAUCH, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1001\/jama.1995.03530140061033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:3:\"274\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1149\";s:8:\"\u0000*\u0000epage\";s:4:\"1151\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"NEUMANN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"H. P. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:6:\"ENG, C\";i:1;s:14:\"MULLIGAN, L. M\";i:2;s:9:\"GLAVAC, D\";i:3;s:10:\"Z\u00c4UNER, I\";i:4;s:15:\"PONDER, B. A. J\";i:5;s:13:\"CROSSEY, P. A\";i:6;s:11:\"MAHER, E. R\";i:7;s:9:\"BRAUCH, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1001\/jama.1995.03530140061033\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:143:\"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II\";s:9:\"\u0000*\u0000jtitle\";s:53:\"JAMA, the journal of the American Medical Association\";s:9:\"\u0000*\u0000stitle\";s:22:\"JAMA j. Am. Med. Assoc\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:3:\"274\";s:8:\"\u0000*\u0000issue\";s:2:\"14\";s:8:\"\u0000*\u0000spage\";s:4:\"1149\";s:8:\"\u0000*\u0000epage\";s:4:\"1151\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0098-7484\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"NEUMANN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"H. P. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:6:\"ENG, C\";i:1;s:14:\"MULLIGAN, L. M\";i:2;s:9:\"GLAVAC, D\";i:3;s:10:\"Z\u00c4UNER, I\";i:4;s:15:\"PONDER, B. A. J\";i:5;s:13:\"CROSSEY, P. A\";i:6;s:11:\"MAHER, E. R\";i:7;s:9:\"BRAUCH, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:143:\"Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II\";s:8:\"\u0000*\u0000place\";s:11:\"Chicago, IL\";s:6:\"\u0000*\u0000pub\";s:28:\"American Medical Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
